Skip Nav Destination
EVIDENCE-BASED MINIREVIEW|
December 8, 2023
When should gene therapy be considered for transfusion-dependent β-thalassemia patients?
Evidence-Based Minireview
Cheryl Mensah,
Cheryl Mensah
1Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
Search for other works by this author on:
Sujit Sheth
2Division of Pediatric Hematology and Oncology, Department of Pediatrics, Weill Cornell Medical College, New York, NY
Correspondence Sujit Sheth MD, Pediatric Hematology Oncology, Weill Cornell Medicine, 525 East 68th Street, P-695, New York, NY 10065. e-mail: shethsu@med.cornell.edu.
Search for other works by this author on:
Hematology Am Soc Hematol Educ Program (2023) 2023 (1): 121–124.
Citation
Cheryl Mensah, Sujit Sheth; When should gene therapy be considered for transfusion-dependent β-thalassemia patients?. Hematology Am Soc Hematol Educ Program 2023; 2023 (1): 121–124. doi: https://doi.org/10.1182/hematology.2023000513
Download citation file:
My Account
Sign In
December 8 2023